A CD8α- Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment.

A CD8α- Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment.
复制标题

DOI:
10.1002/art.40469
复制
发表时间:
2018-07
期刊:
Arthritis & rheumatology (Hoboken, N.J.)
影响因子:
--
通讯作者:
Manfredi AA
Manfredi AA
中科院分区:
其他
文献类型:
--
作者:
Della-Torre E;Bozzalla-Cassione E;Sciorati C;Ruggiero E;Lanzillotta M;Bonfiglio S;Mattoo H;Perugino CA;Bozzolo E;Rovati L;Arcidiacono PG;Balzano G;Lazarevic D;Bonini C;Falconi M;Stone JH;Dagna L;Pillai S;Manfredi AA

文献摘要

参考文献

被引文献

相似文献

非常规的CD 4 + SLAMF 7+细胞毒性TEM细胞(CD 4 + CTL)群体与IgG 4相关疾病(IgG 4-RD)有因果关系。糖皮质激素代表IgG 4-RD患者的一线治疗方法,但其在这种特定疾病中的作用机制仍未知。在这里,我们描述了糖皮质激素对IgG 4-RD中CD 4 + CTL的影响。在基线和糖皮质激素治疗6个月后,通过流式细胞术对18例活动性IgG 4-RD患者的CD 45 RO(TEM)和CD 45 RA(TEMRA)CD 4 + T细胞的效应/记忆区室中的CD 8 α、颗粒酶A、穿孔素和SLAMF 7表达进行定量。18名健康受试者作为对照。对治疗前后IgG 4-RD患者以及受累组织中的循环CD 4 + CTL进行了T细胞受体α和β链基因的下一代测序。与健康对照组相比,IgG 4-RD患者中循环CD 4 + TEM和TEMRA细胞未扩增。CD 4 + SLAMF 7 + TEM细胞(但不是TEMRA细胞)在IgG 4-RD患者中显著增加。在CD 4 + SLAMF 7 + TEM细胞中,IgG 4-RD患者的CD 8 α−细胞升高,但CD 8 α低细胞未升高。外周血中发现的CD 8 α− CD 4 + SLAMF 7 + TEM细胞的相同优势克隆也在受影响的组织中鉴定。CD 8 α−和CD 8 α低CD 4 + SLAMF 7 + TEM细胞均表达细胞溶解分子。糖皮质激素诱导的疾病缓解后,克隆扩增的CD 8 α−而非CD 8 α低CD 4 + SLAMF 7 + TEM细胞减少。CD 8 α− CD 4 + SLAMF 7+细胞毒性TEM细胞亚群在活动性IgG 4-RD患者中寡克隆扩增。该人群在糖皮质激素诱导的缓解后收缩。对该细胞群的进一步表征可以提供预后信息和治疗干预的靶点。
An unconventional population of CD4+SLAMF7+ cytotoxic TEM cells (CD4+CTLs) has been linked causally to IgG4-related disease (IgG4-RD). Glucocorticoids represent the first line therapeutic approach in patients with IgG4-RD but their mechanism of action in this specific condition remains unknown. Here we describe the impact of glucocorticoids on CD4+CTLs in IgG4-RD. CD8α, granzyme A, perforin, and SLAMF7 expression within the effector/memory compartment of CD45RO (TEM) and CD45RA (TEMRA) CD4+ T cells was quantified by flow cytometry in 18 active IgG4-RD patients at baseline and after 6 months of glucocorticoid treatment. Eighteen healthy subjects were studied as controls. Next-generation sequencing of the T-cell receptor α and β chain gene was performed on circulating CD4+CTLs in patients with IgG4-RD before and after treatment, and in affected tissues. Circulating CD4+ TEM and TEMRA cells were not expanded in IgG4-RD patients compared to healthy controls. CD4+SLAMF7+ TEM cells (but not TEMRA cells) were significantly increased among IgG4-RD patients. Within CD4+SLAMF7+ TEM cells, CD8α− but not CD8αlow cells were elevated in IgG4-RD patients. The same dominant clones of CD8α−CD4+SLAMF7+ TEM cells found in the peripheral blood were also identified in affected tissue. Both CD8α− and CD8αlow CD4+SLAMF7+ TEM cells expressed cytolytic molecules. Clonally expanded CD8α− but not CD8αlow CD4+SLAMF7+ TEM cells decreased following glucocorticoid-induced disease remission. A subset of CD8α−CD4+SLAMF7+ cytotoxic TEM cells is oligoclonally expanded in patients with active IgG4-RD. This population contracts following glucocorticoid-induced remission. Further characterization of this cell population may provide prognostic information and targets for therapeutic intervention.
DOI: 10.3389/fimmu.2017.00325
发表时间: 2017
影响因子: 7.3
作者:
Oja AE;Vieira Braga FA;Remmerswaal EB;Kragten NA;Hertoghs KM;Zuo J;Moss PA;van Lier RA;van Gisbergen KP;Hombrink P
通讯作者: Hombrink P
DOI: 10.1136/annrheumdis-2014-205233
发表时间: 2015-01
影响因子: 27.4
作者:
Wallace ZS;Mattoo H;Carruthers M;Mahajan VS;Della Torre E;Lee H;Kulikova M;Deshpande V;Pillai S;Stone JH
通讯作者: Stone JH
慢性丙型肝炎和C中患者的血液和肝脏中不同的CD4+ CD8+双阳性T细胞。
DOI: 10.1371/journal.pone.0020145
发表时间: 2011
期刊: PloS one
影响因子: 3.7
作者:
Nascimbeni M;Pol S;Saunier B
通讯作者: Saunier B
DOI: 10.3109/03009742.2015.1055796
发表时间: 2016-03-03
影响因子: 2.1
作者:
Campochiaro, C.;Ramirez, G. A.;Della-Torre, E.
通讯作者: Della-Torre, E.
DOI: 10.1136/annrheumdis-2014-205799
发表时间: 2015-12
影响因子: 27.4
作者:
Della-Torre E;Feeney E;Deshpande V;Mattoo H;Mahajan V;Kulikova M;Wallace ZS;Carruthers M;Chung RT;Pillai S;Stone JH
通讯作者: Stone JH